|
| Press Releases |
|
 |
|
| Tuesday, April 17, 2018 |
|
|
雅各臣獲《FinanceAsia》雜誌「2018年亞洲最佳企業選舉」選為香港「最佳小型企業」首位 |
| 從事非專利藥及品牌藥品研發、生產、市場推廣及銷售的領先企業─雅各臣科研製藥有限公司（「雅各臣」或「集團」；股份代號：2633）欣然宣佈集團於亞洲權威財經雜誌《FinanceAsia》舉辦的「2018年亞洲最佳企業選舉」中，於香港「最佳小型企業」排名第一。 more info >> |
|
|
Jacobson Pharma Ranked No. 1 in "Hong Kong Best Small-Cap Company" in the "Asia's Best Companies Poll 2018" by FinanceAsia |
| Jacobson Pharma Corporation Limited ("Jacobson Pharma" or the "Group"; Stock Code: 2633), a leading company engaged in the research, development, production, marketing and sale of generic drugs and proprietary medicines, is pleased to announce that Jacobson Pharma ranked no.1 in the category of Hong Kong Best Small-Cap Company in the "Asia's Best Companies Poll 2018" conducted by FinanceAsia, an authoritative financial magazine in Asia. more info >> |
|
| Wednesday, December 20, 2017 |
|
|
Jacobson Pharma Enters Agreements with Shanghai Henlius Biotech Inc. To Tap Biologics Market |
| Jacobson Pharma Corporation Limited today announced that through its wholly-owned subsidiaries, Jacobson Medical (Hong Kong) Limited and Joyful Ascent Limited, it has entered into a Licensing Framework Agreement and a Capital Increase Agreement with a subsidiary of Shanghai Fosun Pharmaceutical (Group) Co., Ltd. namely, Shanghai Henlius Biotech Inc., a technological leader in research and development of biosimilar antibody drugs in China. more info >> |
|
|
雅各臣科研制药与上海复宏汉霖订立协议 进军生物制剂市场 |
| 从事非专利药及品牌药品研发、生产、市场推广及销售的领先企业－雅各臣科研制药有限公司（「雅各臣集团」或「集团」；股份代号：2633）今天公布透过其全资附属公司雅各臣药业（香港）有限公司（「雅各臣药业」）及Joyful Ascent Limited（「认购方」） more info >> |
|
|
雅各臣科研製藥與上海復宏漢霖訂立協議 進軍生物製劑市場 |
| 從事非專利藥及品牌藥品研發、生產、市場推廣及銷售的領先企業－雅各臣科研製藥有限公司（「雅各臣集團」或「集團」；股份代號：2633）今天公佈透過其全資附屬公司雅各臣藥業（香港）有限公司（「雅各臣藥業」）及Joyful Ascent Limited（「認購方」） more info >> |
|
|
Jacobson Pharma Enters Agreements with Shanghai Henlius Biotech Inc. To Tap Biologics Market |
| Jacobson Pharma Corporation Limited ("Jacobson Group" or the "Group"; Stock Code: 2633), a leading company engaged in the research, development, production, marketing and sale of generic drugs and proprietary medicines more info >> |
|
| Wednesday, November 22, 2017 |
|
|
雅各臣公布二零一八财年中期业绩 |
| 从事非专利药及品牌药品研发、生产、市场推广及销售的领先企业─雅各臣科研制药有限公司（「雅各臣」或「公司」；股份代号：2633）今天公布公司及附属公司（统称「集团」）截至二零一七年九月三十日止六个月（「报告期」）的未经审核中期业绩。 more info >> |
|
|
雅各臣公佈二零一八財年中期業績 |
從事非專利藥及品牌藥品研發、生產、市場推廣及銷售的領先企業─雅各臣科研製藥有限公司（「雅各臣」或「公司」；股份代號：2633）今天公佈公司及附屬公司（統稱「集團」）截至二零一七年九月三十日止六個月（「報告期」）的未經審核中期業績。
more info >> |
|
|
Jacobson Pharma Announces FY2018 Interim Results |
| Jacobson Pharma Corporation Limited ("Jacobson Pharma" or the "Company"; Stock Code: 2633), a leading company engaged in the research, development, production, marketing and sale of generic drugs and proprietary medicines, today announced its unaudited interim results of the Company and its subsidiaries (collectively the "Group") for the six months ended 30 September 2017 (the "Reporting Period"). more info >> |
|
| Tuesday, October 3, 2017 |
|
|
雅各臣完成发行本金总额为5亿港元的可换股票据予Dragons 615 Limited及HH InRe JP, Ltd. |
| 从事非专利药及品牌药品研发、生产、市场推广及销售的领先企业─雅各臣科研制药有限公司（「雅各臣」或「集团」；股份代号：2633）欣然宣布已完成发行本金总额为5亿港元的可换股票据予两名认购人 more info >> |
|
|
|
|
|
|
|
|
|
| Latest Press Releases |
|
AdsDrama Introduces Short Drama Advertising Platform Amid Growth in Digital Content Monetization
Mar 18, 2026 15:30: JST
|
|
|
AdsDrama Introduces Short Drama Advertising Platform Amid Growth in Digital Content Monetization
Mar 18, 2026 14:30 HKT/SGT
|
|
|
三菱重工、新しい経営方針「ITO」の実践による優秀事例を顕彰
Mar 18, 2026 14:00: JST
|
|
|
GUOQUAN FOOD (2517.HK) Surging core operating profit, Four Stores Jointly Advancing with Concerted Efforts for Long-Term Growth
Mar 18, 2026 13:54 HKT/SGT
|
|
|
FILMART and EntertainmentPulse 2026 open today
Mar 18, 2026 14:42 JST
|
|
|
Chuangxin Industries Announces 2025 Annual Results
Mar 18, 2026 09:30 HKT/SGT
|
|
|
創新實業公佈2025年全年業績 收入及利潤穩步增長
Mar 18, 2026 09:00 HKT/SGT
|
|
|
创新实业公布2025年全年业绩 收入及利润稳步增长
Mar 18, 2026 00:04 HKT/SGT
|
|
|
Maxon Marks Its Official Entry Into the AEC Market With Its Real-Time Archviz Solution
Mar 17, 2026 23:05: JST
|
|
|
Maxon、リアルタイム建築ビジュアライゼーションソリューションでAEC市場に正式参入
Mar 17, 2026 23:05: JST
|
|
|
Maxon, 실시간 Archviz 솔루션으로 AEC 시장 공식 진출
Mar 17, 2026 22:05 HKT/SGT
|
|
|
Maxon推出即時Archviz解決方案，正式進軍AEC市場
Mar 17, 2026 22:05 HKT/SGT
|
|
|
Maxon推出实时Archviz解决方案，正式进军AEC市场
Mar 17, 2026 22:05 HKT/SGT
|
|
|
Maxon Marks Its Official Entry Into the AEC Market With Its Real-Time Archviz Solution
Mar 17, 2026 22:05 HKT/SGT
|
|
|
FinHarbor Introduces Rapid-Deployment Neobank Platform for 30-Day Go-Live
Mar 17, 2026 22:00: JST
|
|
|
|
|
More News >> |
|
|
|
|
|
